News coverage about Nutraceutical Int'l (NASDAQ:NUTR) has trended positive recently, according to Accern. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nutraceutical Int'l earned a media sentiment score of 0.35 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.2898723325509 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Shares of Nutraceutical Int'l (NASDAQ:NUTR) opened at $41.80 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.40 and a quick ratio of 1.42. The company has a market cap of $386.52, a P/E ratio of 26.97 and a beta of 0.48. Nutraceutical Int'l has a 12-month low of $24.92 and a 12-month high of $42.45.

TRADEMARK VIOLATION WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at

About Nutraceutical Int'l

Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.

Insider Buying and Selling by Quarter for Nutraceutical Int'l (NASDAQ:NUTR)

Receive News & Ratings for Nutraceutical Int'l Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical Int'l and related companies with's FREE daily email newsletter.